Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health In TechHIT -0.97%19 5-Year Yield-on-Cost % is 0.00 as of Aug. 20, 2026. GuruFocus rates HIT with a GF Score™ of 19/100. The stock has 2 warning signs investors should review. Among 998 Software companies, Health In Tech ranks worse than 100200.3% on this metric.
Health In Tech's yield on cost for the quarter that ended in Jun. 2026 was 0.00.
The historical rank and industry rank for Health In Tech's 5-Year Yield-on-Cost % or its related term are showing as below:
HIT's 5-Year Yield-on-Cost % is not ranked *
in the Software industry.
Industry Median: 3.09 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Health In Tech (NAS:HIT) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Health In Tech 5-Year Yield-on-Cost % Related Terms
HIT vs AEYE, IDN, RSSS: 5-Year Yield-on-Cost % Comparison
For the Software - Application subindustry, Health In Tech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health In Tech 5-Year Yield-on-Cost % vs Software Industry
For the Software industry and Technology sector, Health In Tech's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Health In Tech's 5-Year Yield-on-Cost % falls into.
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Therefore, Yield-on-Cost of Health In Tech is calculated as
Health In Tech (HIT) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 20, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Health In Tech and its competitors. According to the industry distribution chart, Health In Tech ranks #999999 out of 998 companies in the Software industry.
Is Health In Tech's 5-Year Yield-on-Cost % too high?
Health In Tech's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, Health In Tech ranks #999999 out of 998 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Health In Tech has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Health In Tech's 5-Year Yield-on-Cost % compare to AEYE and IDN?
According to the Software industry distribution chart, Health In Tech ranks #999999 out of 998 companies for 5-Year Yield-on-Cost %. This places Health In Tech in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Software company?
The median 5-Year Yield-on-Cost % among Software companies is 3.09, based on 998 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Health In Tech and its competitors. For the Software industry, the median 5-Year Yield-on-Cost % is 3.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health In Tech's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health In Tech stock overvalued right now?
Health In Tech (HIT) has a current 5-Year Yield-on-Cost % of 0.00. The current 5-Year Yield-on-Cost % is 0.00. Health In Tech's overall GF Score™ is 19/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Health In Tech (HIT), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.
19GF Score
Get the complete analysis for HIT
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HIT has been successfully added to your 
